Northern Trust Corp X4 Pharmaceuticals, Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Northern Trust Corp holds 1,319,599 shares of XFOR stock, worth $448,663. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,319,599

Previous 1,056,006 24.96%

Holding current value

$448,663

Previous $612,000 44.44%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.54 - $0.86 $142,340 - $226,689	263,593 Added 24.96%	1,319,599 $884,000
Q2 2024 Aug 14, 2024	BUY	$0.58 - $1.47 $880 - $2,231	1,518 Added 0.14%	1,056,006 $612,000
Q1 2024 May 14, 2024	SELL	$0.72 - $1.46 $6,117 - $12,405	-8,497 Reduced 0.8%	1,054,488 $1.47 Million
Q4 2023 Feb 13, 2024	SELL	$0.61 - $0.99 $2,871 - $4,660	-4,708 Reduced 0.44%	1,062,985 $892,000
Q3 2023 Nov 13, 2023	BUY	$1.03 - $2.02 $16,262 - $31,893	15,789 Added 1.5%	1,067,693 $1.16 Million
Q2 2023 Aug 11, 2023	BUY	$0.82 - $2.49 $678,495 - $2.06 Million	827,434 Added 368.62%	1,051,904 $2.04 Million
Q1 2023 May 15, 2023	BUY	$0.8 - $1.22 $62,205 - $94,863	77,757 Added 53.0%	224,470 $195,000
Q4 2022 Feb 13, 2023	BUY	$0.69 - $2.21 $42,452 - $135,972	61,526 Added 72.22%	146,713 $145,000
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.71 $26,175 - $50,292	29,411 Added 52.73%	85,187 $146,000
Q2 2022 Aug 12, 2022	BUY	$0.88 - $1.91 $308 - $668	350 Added 0.63%	55,776 $54,000
Q1 2022 May 13, 2022	SELL	$1.48 - $2.58 $17,875 - $31,161	-12,078 Reduced 17.89%	55,426 $97,000
Q4 2021 Feb 08, 2022	SELL	$1.9 - $5.6 $674 - $1,987	-355 Reduced 0.52%	67,504 $155,000
Q3 2021 Nov 15, 2021	SELL	$4.53 - $6.45 $3,189 - $4,540	-704 Reduced 1.03%	67,859 $359,000
Q2 2021 Aug 13, 2021	SELL	$6.49 - $9.56 $725,705 - $1.07 Million	-111,819 Reduced 61.99%	68,563 $446,000
Q1 2021 May 12, 2021	SELL	$6.63 - $10.28 $182,994 - $283,738	-27,601 Reduced 13.27%	180,382 $1.55 Million
Q4 2020 Feb 11, 2021	SELL	$5.41 - $7.4 $124,711 - $170,584	-23,052 Reduced 9.98%	207,983 $1.34 Million
Q3 2020 Nov 16, 2020	SELL	$6.09 - $9.15 $60,351 - $90,676	-9,910 Reduced 4.11%	231,035 $1.57 Million
Q2 2020 Aug 14, 2020	BUY	$7.98 - $10.44 $457,820 - $598,953	57,371 Added 31.25%	240,945 $2.25 Million
Q1 2020 May 14, 2020	BUY	$6.03 - $11.01 $266,037 - $485,750	44,119 Added 31.64%	183,574 $1.84 Million
Q4 2019 Feb 14, 2020	BUY	$9.93 - $14.33 $251,099 - $362,362	25,287 Added 22.15%	139,455 $1.49 Million
Q3 2019 Nov 13, 2019	BUY	$11.06 - $15.75 $974,209 - $1.39 Million	88,084 Added 337.69%	114,168 $1.45 Million
Q2 2019 Aug 13, 2019	BUY	$12.57 - $21.67 $327,875 - $565,240	26,084 New	26,084 $392,000

Others Institutions Holding XFOR

# of Institutions

105

Shares Held

100M

Call Options Held

213K

Put Options Held

50.6K

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $23.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp X4 Pharmaceuticals, Inc Transaction History